BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2018
View Archived Issues
Tumor T cells mostly just rubbernecking
Read More
"Noncoding" regions produce tumor antigens
Read More
MTH1 expression levels predict breast cancer prognosis
Read More
Inflammasome inhibition is promising antibacterial therapy
Read More
Kiniksa presents interim phase II data for rilonacept and initiates phase III RHAPSODY study
Read More
ABHD12 regulates immunostimulatory lipid pathways in vivo
Read More
Novel pyrimidopyrimidinone derivative JND-3229 inhibits EGFR C797S mutant
Read More
CEPI and Imperial College London partner to develop saRNA vaccine platform
Read More
FDA clears IND for Y-mAbs' bispecific GD2 antibody
Read More
Almirall and X-Chem to develop oral dermatological treatments
Read More
First subject enrolled in phase I/IIa study of AR-501
Read More
Novel model of ALS discounts protein transmission hypothesis in disease pathogenesis
Read More
Phase IIb T-Force GOLD study of valbenazine does not meet primary endpoint
Read More
JMX-0293 inhibits tumor growth in preclinical models of TNBC
Read More
Praxis Precision Medicines investigates repurposing sodium channel blocker for epilepsy
Read More
Phase II study of bermekimab in atopic dermatitis meets endpoints
Read More
Nflection Therapeutics discovers MAPKK 1 inhibitors
Read More
Prostanoid EP2/EP4 receptor antagonists patented by Idorsia Pharmaceuticals
Read More
Mutation in the telomere length control protein TZAP is associated with poor breast cancer prognosis
Read More
Sosei Heptares initiates first-in-human study with mGlu5 NAM HTL-0014242
Read More
Denali Therapeutics presents new RIPK1 inhibitors
Read More
KDM5B inhibitors divulged by the University of Texas
Read More
Superb Wisdom describes new resiquimod derivatives
Read More
No signs of clinical activity at 6 months with rAAV2tYF-CB-hRS1 in X-linked retinoschisis
Read More
Merck & Co. and Instituto Butantan to develop dengue vaccines
Read More
Entera Bio and Amgen collaborate on oral large molecule programs
Read More